Retrospective analysis of the risk factors, outcome, antimicrobial cost and susceptibility for bacteremia caused by ESBL-producing enterobacteriaceae

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT1040230081

Enrollment

1000

Registered

2023-09-25

Start date

2023-10-02

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bacteremia bacteremia

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: inpatient from 4/1/201 to 3/31/2023 bacteremia caused by enterobacteriaceae

Exclusion criteria

Exclusion criteria: contamination

Design outcomes

Primary

Measure	Time frame
compare esbl group and non-esbl group	—

Secondary

Measure	Time frame
outcome cost of antimicrobial therapy susceptibility	—

Contacts

Public ContactJun Kato

Pharmacy

jyun.katou@hospital.yaizu.shizuoka.jp+81-54-623-3111

Outcome results